Sign Up to like & get
recommendations!
2
Published in 2022 at "ChemMedChem"
DOI: 10.1002/cmdc.202200320
Abstract: Multifactorial diseases exhibit a complex pathophysiology with several factors contributing to their pathogenesis and development. Examples of such disorders are neurodegenerative (e. g. Alzheimer's, Parkinson's) and cardiovascular diseases (e. g. atherosclerosis, metabolic syndrome, diabetes II). Traditional therapeutic…
read more here.
Keywords:
multitarget agents;
improved antidiabetic;
multitarget;
antidiabetic drugs ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14213
Abstract: Absolute treatment effects—i.e. numbers needed to treat (NNTs)—of novel antidiabetic drugs for cardiovascular outcomes have not been comprehensively evaluated. We aimed to perform a meta‐analysis of digitalized individual patient outcomes to display and compare absolute…
read more here.
Keywords:
novel antidiabetic;
antidiabetic drugs;
numbers needed;
drugs cardiovascular ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.70241
Abstract: Cardiac arrhythmias pose a major health concern while the role of antidiabetic medications in cardiac arrhythmic risks is not fully understood.
read more here.
Keywords:
drugs cardiac;
antidiabetic drugs;
therapeutic potential;
exploring therapeutic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5882
Abstract: The purpose of this study is to evaluate the pattern, appropriateness, and cost of antidiabetic drugs prescribed for patients with Type 2 diabetes at primary healthcare facilities (PHFs) in China.
read more here.
Keywords:
antidiabetic drugs;
type diabetes;
disparity guideline;
healthcare facilities ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Current Diabetes Reports"
DOI: 10.1007/s11892-017-0884-1
Abstract: Purpose of ReviewPatients with diabetes and/or stress hyperglycemia requires good glycemic control in the hospital setting, often requiring the use of glucose-lowering therapy. Standard-of-care dictates that non-insulin therapy be discontinued, with insulin therapy initiated using…
read more here.
Keywords:
antidiabetic drugs;
safety;
insulin therapy;
cardiovascular safety ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Drug discovery today"
DOI: 10.1016/j.drudis.2018.08.005
Abstract: Inflammatory responses have a pivotal role in the development of diabetic nephropathy (DN). The nod-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome is a newly recognized and potent inflammatory mediator that induces inflammatory responses in…
read more here.
Keywords:
antidiabetic drugs;
drugs nlrp3;
inflammasome activity;
effects antidiabetic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug discovery today"
DOI: 10.1016/j.drudis.2022.02.006
Abstract: Reverse cholesterol transport (RCT) is a physiological process that reduces excess cholesterol in the body. Cholesterol efflux (CE), an important step in RCT, is mainly mediated by ATP-binding cassette transporters A1 and G1 and has…
read more here.
Keywords:
antidiabetic drugs;
efflux clinical;
cholesterol;
drugs cholesterol ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2017.09.019
Abstract: Cardiovascular disease (CVD) is the major cause of morbidity and mortality for individuals with type 2 diabetes (T2D). In particular, the risk for stroke is twice that of patients without diabetes, and diabetes may be…
read more here.
Keywords:
antidiabetic drugs;
risk;
stroke risk;
evidence ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Diabetes and Its Complications"
DOI: 10.1016/j.jdiacomp.2020.107723
Abstract: Inflammation is implicated in the development and severity of the coronavirus disease 2019 (COVID-19), as well as in the pathophysiology of diabetes. Diabetes, especially when uncontrolled, is also recognized as an important risk factor for…
read more here.
Keywords:
anti inflammatory;
antidiabetic drugs;
era;
properties antidiabetic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2019.154001
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western societies and a major cause of hepatic disease worldwide. Its more severe type, namely nonalcoholic steatohepatitis (NASH), may result in the…
read more here.
Keywords:
antidiabetic drugs;
fatty liver;
effects newer;
disease ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Psychoneuroendocrinology"
DOI: 10.1016/j.psyneuen.2022.105715
Abstract: OBJECTIVE Diabetes type 2 is associated with depression, but the impact of antidiabetic drugs is not clear. The objective was to analyze the association between diabetes type 2, antidiabetic drugs, and depression. METHODS This register-based…
read more here.
Keywords:
antidiabetic drugs;
study;
patients diabetes;
depression ... See more keywords